ald-301
Cell therapyexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2013 (NCT01774097)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ald-301
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01774097 | Phase 2 | Jun 1, 2013 | Aldagen, Baylor University, Cardiovascular Cell Therapy Research Network, National Heart, Lung, and Blood Institute (NHLBI), University of Texas at Houston |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aldagen | For profit | 1 | 0 | 1 | 2013 |
| Baylor University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Cardiovascular Cell Therapy Research Network | Academic/Hospital | 1 | 0 | 1 | 2013 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2013 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2013 |
5 organizations
Page 1 / 1